Scalp cooling as a strategy to reduce alopecia induced by cancer chemotherapy: systematic review




alopecia; drug therapy; oncology nursing; Cryotherapy; Complementary therapies.


Objective: To analyze the available evidence on the use of the scalp cooling technique in reducing alopecia in cancer patients undergoing chemotherapy and its repercussions for nursing care. Method: Systematic review based on PRISMA checklist recommendations, without date restrictions, in the following databases: Pubmed, Cinahal, Cochrane and Scopus. Results: Of 579 published articles, 10 were included published between 2015 and 2020. Patients who used the therapy were more successful in terms of capillary preservation, ranging from 45.6% response with grade 3 assessment of alopecia, to 89% with rate greater than 50% of alopecia using taxanes. It is important to emphasize that there are cases of failure or partial fall and the factors that can influence this result. Conclusion: The effectiveness of the technique and the importance of nursing in this process were evidenced in order to provide a better quality of life and treatment for these patients.


Bajpai, J., Kagwade, S., Chandrasekharan, A., Dandekan, S., Kanan, S., Kembhavi Y. et al. (2019). Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia. The Breast. 49:187-193.

Brasil. (2020). Ministério da Saúde. Instituto Nacional do Câncer. Incidência de Câncer no Brasil. Estimativa

Brasil. (2008). Ministério da Saúde. Instituto Nacional do Câncer. Ações de enfermagem para o controle do câncer: uma proposta de integração ensino-serviço. (3a ed.).

Brasil. (2016). Ministério da Saúde. Conselho Nacional de Saúde. Resolução nº 510, de 7 de abril de 2016. Diário Oficial da República Federativa do Brasil, Brasília, DF 24 de maio de 2016.

Breed, W. P., Van den Hurk, C. J., & Peerbooms, M. (2011). Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potencials and limitations. Expert rev. dermatol. 6(1) 109-25. 10.1586/edm.10.76

Cigler, T., Isseroff, D., Fiederlein, B., Schneider, S., Chuang, E., Vahdat, L., et al. (2015). Study CrossMark Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy. Clin Breast Cancer. (5):332-4. 10.1016/j.clbc.2015.01.003.

Common terminology criteria for adverse events (CTCAE). (2020).

Critical Appraisal Skills Programme. CASP checklist. (2014). CASP.

Dean, et al. (1979). Preventions of Doxorrubicin-Induced Hair Loss with Scalp Hypothermia. N Engl J Med. 301(26):1427-9. 10.1056/NEJM197912273012605.

Ferreira, J. C., & Patino, C. M. (2018). Avaliação crítica da literatura. Por que nos importamos?. Jornal Brasileiro de Pneumologia. 44(6):448. 37562018000000364.

Friedrichs, K., & Cartensen, M. H. (2014). Successful reduction of alopecia induced by antracycline and taxane containing adjuvante chemotherapy in breast câncer – clinical evaluation of sensor-controlled scalp cooling. Springerplus. 3:500. 10.1186/2193-1801-3-500.

Gianotti, E., Razzini, G., Bini, M., Crivellaro, C., Righi, A. Darecchio, S. et al. (2019). Scalp Cooling in Daily Clinical Practice for Breast Cancer Patients Undergoing Curative Chemotherapy: A Multicenter Interventional Study. Asia Pac J Clin Oncol Nurs. 6(3), 277–82. 10.4103/apjon.apjon_4_19

Kinoshita, T., Nakayama, T., Fukuma, E., Inokuchi, M., Ishiguro, H., Ogo, E. et al. (2019). Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy-Induced Alopecia in Breast Cancer Patients: The HOPE Study. Front Oncol. 9: 733.

Komen, M. M. C., Hurk, C. J. G., Nortier, J. W. R. & Ploeg, T. V. (2018). Paciente-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia. Eur J Oncol Nurs. 33: 49-55.

Melnyk, B. M., & Fineout-Overholt, E. (2011) Evidence-based practice in nursing & healthcare: a guide to best practice. Philadelphia: Wolters Kluwer, Lippincott Williams & Wilkins. p.3-24.

Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med. 6(7):1-6.

Nangia, J., Wang, T., Osborne, C., Niravath, P., Otte, K., Papish, S., et al. (2017). Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer: The SCALP randomized clinical trial. JAMA. 317(6):596–605. 10.1001/jama.2016.20939.

Ohsumi, S.; Kiyoto, S.; Takahashi, M., Hara, F., Takashima, S., Aogi, K., et al. (2020). Scalp cooling for hair prevention in female Japanese Breast cancer paientes receiving (neo)adjuvant chemotherapy. Support. care cancer. 29, 437–443.

Orlando, L., Loparco, D., Fedele, P., Schiavore, P., Quaranta, A., Caliolo, C., et al. (2019). Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia. Future Oncol. 15, 29.

Polit, D. F, & Beck, C. T. (2019). Fundamentos de pesquisa em enfermagem: avaliação de evidências para a prática da enfermagem. (9a ed.), Ed. Artmed.

Ross, M., & Carttlidge, E. F. (2017). Scalp Cooling – A literature review of efficacy, safety, and tolerability for chemotherapy-induced alopecia. Clin J Oncol Nurs. 21(2):226-233. 10.1188/17.CJON.226-233.

Rice, B. A., Ver Hoeve, E. S., DeLuca, A. N., Esserman, L. J., Rugo, H. S., & Melisko, M. E. (2018). Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat. 167(1):117–22.

Rugo, H. S., Klein, P., Melin, S. A., Hurvitz, S. A., Melisko, M. E., Moore A, et al. (2017). Association between use of a scalp cooling device and alopecia after chemotherapy for breast cancer. JAMA. 317(6):606–14. 10.1001/jama.2016.21038.

Roe, H. (2014). Scalp cooling: management option for chemotherapy-induced alopecia. Br. j. nurs. 2014; 23(16). 10.12968/bjon.2014.23.Sup16.S4.

Schaffrin, N.D., Shmitz, I., Josten, N.A., Hern, U. V., & Voigtmann, R. (2015). The influence of various parameters on the success of Sensor-controlled scalp cooling in preventing chemotherapy-induced alopecia. Oncol Res Treat. 38:489-495. 10.1159/000440636.

Silva, G. B., Ciccolini, K., Donati, A., & Hurk, C. V. D. (2020). Scalp cooling to prevent chemotherapy-induced alopecia. An Bras Dermatol. 95(5):631–7.

Smetanay, K., Junio, P., Feißt, M., Seitz, J., Hassel, J. C., Mayer, L., et al. (2019). COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer. Breast Cancer Res Treat. 173(1):135–43.

Souza, M. T., & Silva, M. D., (2010). Carvalho R. Revisão integrativa: o que é e como fazer. Einstein. 8(1 Pt 1):102-6.

Van den Hurk, C. J., Peerbooms, M., Van de Poll-Franse, L. V., Nortier, J. W., Coe- bergh, J. W., & Breed, W. P. (2012). Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry. Acta Oncol. 51: 497–504. 10.3109/0284186X.2012.658966.

Young, A., Arif, A. (2016). The use of scalp cooling for chemotherapy-induced hair loss. Br J Nurs. 25(10), S22–7.



How to Cite

MONTEIRO, D. E.; FIALHO, I. C. T. S. .; RAMOS, F. C. de S. . .; OLIVEIRA, R. M. M. de .; NASCIMENTO, C. T. do .; SOUZA, O. M. de; FULY, P. dos S. C. . Scalp cooling as a strategy to reduce alopecia induced by cancer chemotherapy: systematic review. Research, Society and Development, [S. l.], v. 10, n. 13, p. e265101321118, 2021. DOI: 10.33448/rsd-v10i13.21118. Disponível em: Acesso em: 8 dec. 2021.



Review Article